Chloroquine/Hydroxychloroquine AND SARS-CoV 2; lessons from case-control studies
Authors
Abstract:
Chloroquine has several disadvantages consisting hypoglycemia, diarrhea, prolong QTc interval, and AV block (21-22). In addition, Gendelman et al., recently published an article about inefficacy of continuous Hydroxychloroquine or colchicine therapy for prevention of SARS-CoV 2 infection (23). According to recent RCTs, HCQ has no therapeutic effects on prevention or improvment of major outcomes in COVID-19 patients (24-25). According to current analysis, it seems that CQ/HCQ has not benefit in treatment of COVID-19 patients. But we have several limitations such as 1) high heterogeneity rate which reduce reliability of analysis, 2) presence of publication bias, 3) dosage of CQ/HCQ was varying among the included studies, 4) different outcome between studies, 5) various in times of evaluating outcomes, and 6) low sample size. We need to complete further clini0002cal trials to confirmed our results
similar resources
Whole-inactivated SARS-CoV-2 vaccines: from fear to hope
Undoubtedly, vaccination can be one of the promising approaches to control infectious diseases such as the COVID-19 pandemic. Inactivated viral vaccines have a history of "vaccine-induced enhanced disease", which may occur when neutralizing antibodies bind to viral antigens without blocking or clearing the infection. This can cause additional inflammation through the mechanisms described for ot...
full textSARS-CoV-2 infection: its psychiatric manifestations
Background: The clinical presentation of SARS-CoV-2 infection was initially dominated by respiratory symptoms. However the clinical spectrum is wide and neuropsychiatric syndromes are also a source of medical concern. Our aims are to present an atypical clinical presentation of SARS-CoV-2 infection characterized by auditory hallucinations and unusual behavior and to emphasize the diversity of ...
full textمروری به بررسی ایمونولوژیکی SARS-Cov-2
زمینه و هدف بیماری کووید-19 یک بیماری عفونی به‌شدت مسری می‌باشد که توسط یک کروناویروس جدید ایجاد می‌شود که می‌تواند از انسان به انسان از طریق تماس نزدیک منتقل شود. هدف از مطالعه حاضر بررسی اطلاعات جدید در زمینه ایمونولوژی کووید-19 می‌باشد. مواد و روش‌ها در مطالعه مروری حاضر، از موتورهای جستجوی Google و Google Scholar و مقالات نمایه شده در پایگاه‌های علمی معتبر بین‌المللی از جمله Pub Med، MedLi...
full textSerology Testing for SARS-CoV-2: Benefits and Challenges
As COVID-19 was declared as a pandemic by the World Health Organization (WHO) in March 2020, it is an emerging need to discuss different aspects of this pandemic. In any pandemic, valid and rapid laboratory diagnostic tests are critically important for early diagnosis, which will increase the rate of successful treatment and more importantly prevent the spread of the disease.
full textSARS-CoV-2 and COVID-19, evidence from a literature review: review article
SARS-CoV-2 emerging from Wuhan, China is a member of the Coronaviridae family, which has so far infected and killed many people. The SARS-CoV-2 pandemic affected various aspects of life in Iran and Worldwide, and governments have imposed quarantines and travel bans on an unprecedented scale. The virus causes COVID-19, which can spread through close contact with the infected person, contaminat...
full textSARS-COV-2 Virus; Immune Responses and The Immunopathogenesis
Abstract Background and Objectives Clinical features of SARS-COV-2 virus include fever, headache, cough, sore throat, and shortness of breath, and in severe forms it leads to disseminated intravascular coagulation, septic shock, and ultimately death. Excessive secretion of proinflammatory cytokines such as TNF-α, IL-6, and IL-1 leads to cytokine storms in this disease. The emergence of new va...
full textMy Resources
Journal title
volume 14 issue None
pages 0- 0
publication date 2020-12
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023